Search

everythinglearnresearchcommunity

for

Search:↓

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Nearly all elderly nursing home residents had a skin disease, with dry skin being the most common.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

Pregnant women often experience skin and hair changes, with over half getting stretch marks and pigment changes, and should be cautious with cosmetic procedures due to potential risks.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Premature hair graying in young men is linked to family history, obesity, and smoking.

Obese women with PCOS are more likely to have fatty liver disease.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

Hormonal therapies are safe and effective for treating adult women's acne.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

Melatonin may help treat PCOS symptoms in rats.

Certain diets can affect skin conditions, but more research is needed to understand these relationships fully.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.